Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ZBIOZBIO
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ZENAS BIOPHARMA INC

Yes. Geode Capital Management holds 882,654 shares of ZBIO (Zenas Biopharma), worth $22.4M, as of its Q2 2026 13F filing. It increased the position by 226,869 shares (+34.6%) from Q1 2026. Geode Capital Management has held ZBIO in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$22.4M

Current Shares

882,654

Total Value Change

+$22M

Total Shares Change

+857,797

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
882,654
+34.6%
$22.4M0.0%$25.38
37
2026-Q1
Increased
655,785
+11.4%
$12.8M0.0%$25.18
31
2025-Q4
Increased
588,393
+25.2%
$21.4M0.0%$36.58
35
2025-Q3
Increased
470,035
+25.8%
$10.4M0.0%$20.57
34
2025-Q2
Increased
373,617
+4.6%
$3.6M0.0%$9.58
28
2025-Q1
Increased
357,156
+2.4%
$2.8M0.0%$8.17
27
2024-Q4
Increased
348,760
+1303.1%
$2.9M0.0%$8.99
42
2024-Q3
New
24,857
-
$420,5800.0%$17.14
37

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used